slotkoers
Korea S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.110
KRW
|
-.--%
|
|
-4,01%
|
-27,08%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
157.772
|
132.693
|
148.527
|
408.921
|
108.036
|
91.605
|
Bedrijfswaarde
1 |
132.165
|
111.394
|
133.299
|
327.508
|
43.978
|
39.444
|
K/w-verhouding
|
-26,7
x
|
-14,7
x
|
-9,88
x
|
-9,3
x
|
-4,16
x
|
-4,37
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
77,5
x
|
31,3
x
|
44,2
x
|
126
x
|
20,4
x
|
29,3
x
|
Bedrijfswaarde/omzet
|
64,9
x
|
26,2
x
|
39,6
x
|
101
x
|
8,31
x
|
12,6
x
|
Bedrijfswaarde/EBITDA
|
-16,9
x
|
-12,9
x
|
-10,4
x
|
-9,65
x
|
-1,93
x
|
-1,58
x
|
Bedrijfswaarde/FCF
|
-
|
-13.707.748
x
|
-12.699.051
x
|
-16.006.942
x
|
-2.832.044
x
|
-2.902.518
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
6,76
x
|
6,97
x
|
11,5
x
|
4,6
x
|
1,62
x
|
1,82
x
|
Aantal aandelen (in duizenden)
|
13.194
|
13.786
|
13.979
|
21.409
|
21.478
|
21.478
|
Referentieprijs
2 |
11.958
|
9.625
|
10.625
|
19.100
|
5.030
|
4.265
|
Datum van publicatie
|
17/03/20
|
17/03/20
|
17/03/21
|
18/03/22
|
15/03/23
|
18/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
2.035
|
4.245
|
3.363
|
3.242
|
5.293
|
3.125
|
EBITDA
1 |
-7.823
|
-8.652
|
-12.821
|
-33.934
|
-22.798
|
-24.949
|
Bedrijfsresultaat (EBIT)
1 |
-8.266
|
-9.355
|
-13.675
|
-35.004
|
-24.089
|
-27.086
|
Operationele Marge
|
-406,13%
|
-220,35%
|
-406,57%
|
-1.079,66%
|
-455,07%
|
-866,63%
|
Resultaat voor belastingen (EBT)
1 |
-7.192
|
-8.740
|
-15.313
|
-34.653
|
-27.657
|
-22.430
|
Nettowinst (verlies)
1 |
-5.908
|
-8.740
|
-14.863
|
-34.569
|
-25.953
|
-21.106
|
Nettomarge
|
-290,27%
|
-205,88%
|
-441,9%
|
-1.066,25%
|
-490,29%
|
-675,3%
|
WPA
2 |
-448,2
|
-655,0
|
-1.075
|
-2.053
|
-1.210
|
-975,1
|
Free Cash Flow
|
-
|
-8.126
|
-10.497
|
-20.460
|
-15.529
|
-13.590
|
FCF-marge
|
-
|
-191,42%
|
-312,09%
|
-631,08%
|
-293,36%
|
-434,81%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
17/03/20
|
17/03/20
|
17/03/21
|
18/03/22
|
15/03/23
|
18/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
25.607
|
21.299
|
15.228
|
81.413
|
64.058
|
52.161
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-8.126
|
-10.497
|
-20.460
|
-15.529
|
-13.590
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-41,3%
|
-93,1%
|
-67,9%
|
-33,5%
|
-33,7%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-11,5%
|
-18,6%
|
-29,3%
|
-16,2%
|
-21,4%
|
Totale activa
1 |
-
|
75.757
|
79.767
|
118.050
|
159.775
|
98.797
|
Nettoactief per aandeel
2 |
1.769
|
1.380
|
923,0
|
4.156
|
3.107
|
2.339
|
Cashflow per aandeel
2 |
51,60
|
278,0
|
195,0
|
124,0
|
95,30
|
203,0
|
Capex
1 |
243
|
991
|
2.034
|
2.378
|
768
|
1.385
|
Capex/omzet
|
11,96%
|
23,34%
|
60,47%
|
73,34%
|
14,51%
|
44,33%
|
Datum van publicatie
|
17/03/20
|
17/03/20
|
17/03/21
|
18/03/22
|
15/03/23
|
18/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -27,08% | 60,74 mln. | | +33,25% | 704 mld. | | +28,59% | 577 mld. | | -3,55% | 348 mld. | | +18,16% | 327 mld. | | +4,36% | 288 mld. | | +14,81% | 234 mld. | | +4,93% | 198 mld. | | -9,78% | 194 mld. | | -3,69% | 147 mld. |
Farmaceutische producten - Andere
|